Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Pancreatitis
Studies from Sichuan University add new findings in the area of acute pancreatitis
March 23rd, 2008
In this recently published study, investigators in Chengdu, People's Republic of China conducted a study "To evaluate the therapeutic effect of alanylglutamine dipeptide (AGD) in the treatment of severe acute pancreatitis (SAP) in early and advanced stage. Eighty patients with SAP were randomized and received 100 mL/d of 20% AGD intravenously for 10 d starting either on the day of (early treatment group) or 5 d after (late treatment group) admission." "Groups had similar demographics, underlying diseases, Ranson score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, and Balthazar's computed tomography (CT) score at the beginning of the study and...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-23)
|
